Skip to main content

Advertisement

Log in

Cytotoxic Effect of Doxorubicin on Human Multiple Myeloma Cells In Vitro

  • Oncology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Cytotoxic effect of doxorubicin in human multiple myeloma cell cultures RPMI 1640, RPMI 8226, and IM-9 was studied. The obtained data were compared with mRNA expression of MDR1, MRP1, BCRP, LRP genes responsible for the development of multiple drug resistance. IM-9 cells that differed from the other two cultures by the expression of surface differentiation markers and by mRNA expression of MDR1, BCRP, and LRP were most sensitive to doxorubicin. All cells expressed mRNA for only A-isoform of insulin receptor (IRA), while B-isoform (IRB) was not expressed. Insulin in a concentration of 5 μg/ml had no effect on the cytotoxic effect of doxorubicin in the studied cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. O. M. Votyakova and E. A. Demina, Multiple Myeloma. Clinical Oncohematology. Clinical Guidelines, Ed. M. A. Volkova [in Russian], Moscow (2007), pp. 847–873.

  2. A. A. Stavrovskaya, Sorovskiy Obrazovat. Zhurn., 7, No. 7, 17–23 (2001).

    Google Scholar 

  3. A. A. Stavrovskaya, Biol. Membrany, 20, No. 3, 196–205 (2003).

    CAS  Google Scholar 

  4. S. S. Shushanov, Bull. Exp. Biol. Med., 150, No. 1, 42–44 (2010).

    Article  PubMed  CAS  Google Scholar 

  5. S. S. Shushanov, Bull. Exp. Biol. Med., 152, No. 2, 202–205 (2011).

    Article  PubMed  CAS  Google Scholar 

  6. S. S. Shushanov, L. G. Mar’ina, Yu. B. Chernykh, et al., Klin. Onkogematol., 3, No. 2, 105–113 (2010).

    Google Scholar 

  7. K. C. Anderson, R. A. Kyle, W. S. Dalton, et al., Hematology, 2000, No. 1, 147–165 (2000).

    Article  Google Scholar 

  8. A. Dispenzieri and R. A. Kyle, Best Pract. Res. Clin. Haematol., 18, No. 4, 553–568 (2005).

    Article  PubMed  CAS  Google Scholar 

  9. G. G. Freund, D. T. Kulas, and R. A. Mooney, J. Immunol., 151, No. 4, 1811–1820 (1993).

    PubMed  CAS  Google Scholar 

  10. J. Hatok, P. Račay, J. Hudeček, and D. Dobrota, Biologia, Bratislava, 61, No. 3, 247–256 (2006).

    Article  CAS  Google Scholar 

  11. L. A. Hazlehurst, J. S. Damiano, I. Buyuksal, et al., Oncogene, 19, No. 3, 4319–4327 (2000).

    Article  PubMed  CAS  Google Scholar 

  12. T. Hideshima, P. L. Bergsagel, W. M. Kuehl, and K. C. Anderson, Blood, 104, No. 38, 607–618 (2004).

    Article  PubMed  CAS  Google Scholar 

  13. N. Kalitin, M. Kostjukova, E. Kakpakova, et al., Eur. J. Cancer, 47, No. 1, S644 (2011).

    Article  Google Scholar 

  14. P. Sonneveld, J. Intern. Med., 247, No. 5, 521–534 (2000).

    PubMed  CAS  Google Scholar 

  15. A. C. Sprynski, D. Hose, A. Kassambara, et al., Leukemia, 24, No. 11, 1940–1950 (2010).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. S. Shushanov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 155, No. 2, pp. 195-200, February, 2013

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shushanov, S.S., Kravtsova, T.A. Cytotoxic Effect of Doxorubicin on Human Multiple Myeloma Cells In Vitro . Bull Exp Biol Med 155, 228–232 (2013). https://doi.org/10.1007/s10517-013-2120-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-013-2120-6

Key Words

Navigation